Plain-English translation of NCT06319300 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers studied whether an artificial intelligence-assisted insulin dose adjustment system could help patients with type 2 diabetes achieve better blood sugar control while hospitalized. The trial compared this AI system to the standard approach where doctors manually adjusted insulin doses based on blood sugar readings. The goal was to see if the AI system was both more effective and safe than traditional insulin management.
Managing insulin doses in hospitalized patients with type 2 diabetes can be complex and time-consuming for doctors. This trial investigated whether artificial intelligence could help make insulin adjustments faster and more accurate, potentially improving patient outcomes and reducing the risk of dangerously high or low blood sugar events.
Participants who enrolled were randomly assigned to one of two groups while hospitalized. One group had their insulin doses adjusted using the artificial intelligence system, while the other group received insulin adjustments from their doctors in the usual way. Throughout their hospital stay, researchers monitored blood sugar levels and watched for any side effects to compare how well each approach worked.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
China